124 results on '"Tang, W.H. Wilson"'
Search Results
2. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
3. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
4. Burden of Pediatric Heart Failure in the United States
5. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
6. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review
7. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release
8. Gut Microbiome-Based Management of Patients With Heart Failure
9. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
10. Hyponatremia in Acute Decompensated Heart Failure: Depletion Versus Dilution
11. The Pathophysiological Role of Interstitial Sodium in Heart Failure
12. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis
13. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
14. Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart Failure
15. Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival: Importance of Sustained Decongestion
16. PROGNOSTIC VALUE AND PREDICTORS OF DECREASED SKELETAL MUSCLE MASS ON CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS UNDERGOING AORTIC VALVE SURGERY
17. Insights From a Cardiac Resynchronization Optimization Clinic as Part of a Heart Failure Disease Management Program
18. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
19. Persistent Hemodynamic Benefits of Cardiac Resynchronization Therapy With Disease Progression in Advanced Heart Failure
20. The Year in Heart Failure
21. Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: Insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System
22. Sodium Nitroprusside for Advanced Low-Output Heart Failure
23. Evaluation and Long-Term Prognosis of New-Onset, Transient, and Persistent Anemia in Ambulatory Patients With Chronic Heart Failure
24. Elevated Intra-Abdominal Pressure in Acute Decompensated Heart Failure: A Potential Contributor to Worsening Renal Function?
25. The Year in Heart Failure
26. Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure
27. The Year in Heart Failure
28. Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy
29. THE ADDITIONAL VALUE OF NATURAL LANGUAGE PROCESSING TO IDENTIFY DISEASE PREVALENCE BASED ON ELECTRONIC MEDICAL RECORD IMAGING REPORTS
30. INFLUENCE OF SEX ON THE PROGNOSTIC IMPACT OF CARDIAC MAGNETIC RESONANCE IMAGING QUANTIFICATION OF FUNCTIONAL MITRAL REGURGITATION IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY
31. PERFORMANCE AND ACCURACY OF NATURAL LANGUAGE PROCESSING TO IDENTIFY DISEASE ETIOLOGY FROM NON-STRUCTURED CARDIAC MAGNETIC RESONANCE IMAGING ELECTRONIC MEDICAL RECORD REPORTS
32. Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output
33. Intensive Blood Pressure Control and Body Size
34. RELATIONSHIP BETWEEN STATIN USE AND TRIMETHYLAMINE N-OXIDE IN CARDIOVASCULAR RISK ASSESSMENT
35. Reply
36. Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
37. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure
38. CIRCULATING INTESTINAL FATTY ACID-BINDING PROTEIN (I-FABP) LEVELS PORTENDS HIGHER RISK OF ADVERSE CLINICAL OUTCOMES IN ADVANCED DECOMPENSATED HEART FAILURE
39. PARADOXICAL IMPACT OF PROPORTIONAL PULSE PRESSURE ON MORTALITY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
40. EXERCISE INTOLERANCE AND PROPORTIONAL PULSE PRESSURE RESPONSE IN PATIENTS WITH CHRONIC HEART FAILURE
41. IMPACT OF PROPORTIONAL PULSE PRESSURE ON EXERCISE TOLERANCE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
42. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β 1 -Adrenergic Receptors
43. Reply
44. Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney Disease ∗
45. Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
46. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure
47. RIGHT VENTRICULAR FDG-PET UPTAKE SUGGESTS A SHIFT TO GLYCOLYTIC METABOLISM IN THE SETTING OF RIGHT VENTRICULAR DYSFUNCTION RELATED TO PULMONARY ARTERIAL HYPERTENSION
48. A Test in Context
49. Reply
50. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.